Paperpal Prime Logo

American Journal of Cardiovascular Drugs : Impact Factor & More

eISSN: 1179-187XpISSN: 1175-3277

Key Metrics

CiteScore
5.9
Eigenfactor
0.001 - 0.005
H-Index
57
Impact Factor
< 5
SJR
Q2Pharmacology (medical)
SNIP
1.15
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on American Journal of Cardiovascular Drugs

American Journal of Cardiovascular Drugs Journal Specifications

Overview
Publisher ADIS INT LTD
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2001
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in American Journal of Cardiovascular Drugs ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in American Journal of Cardiovascular Drugs

Antihypertensive Efficacy and Safety of Angiotensin Receptor Blockers (ARBs) with and without Inverse Agonism: A Systematic Review and Network Meta-analysis.
  • 8 Aug 2026
  • American journal of cardiovascular drugs : drugs, devices, and other interventions
Adherence and Healthcare Costs Associated with Single-vs Free-Pill Combination of Perindopril-Based Antihypertensive Medications: An 11-Year Follow-Up, Real-World Evidence.
  • 7 Aug 2026
  • American journal of cardiovascular drugs : drugs, devices, and other interventions
When Methods Matter: An Umbrella Review of Lorundrostat and the Impact of Analytical Decisions on Reported Blood Pressure and Safety Outcomes.
  • 23 Jul 2026
  • American journal of cardiovascular drugs : drugs, devices, and other interventions
Aspirin Versus Clopidogrel as Single Antiplatelet Therapy After TAVI: A Propensity Score-Matched, Retrospective Analysis.
  • 21 Jul 2026
  • American journal of cardiovascular drugs : drugs, devices, and other interventions
Empagliflozin in STEMI Patients: A Randomized Controlled Trial on Left Ventricular Recovery and Cardiovascular Outcomes.
  • 17 Jul 2026
  • American journal of cardiovascular drugs : drugs, devices, and other interventions
Food Effects on the Pharmacokinetics of Single Dose and Steady-State Ralinepag, a Novel Oral Prostacyclin Agonist, in Healthy Volunteers.
  • 16 Jul 2026
  • American journal of cardiovascular drugs : drugs, devices, and other interventions
Antihypertensive Efficacy and Safety of Angiotensin Receptor Blockers (ARBs) with and without Inverse Agonism: A Systematic Review and Network Meta-analysis.
  • 8 Aug 2026
  • American journal of cardiovascular drugs : drugs, devices, and other interventions
Adherence and Healthcare Costs Associated with Single-vs Free-Pill Combination of Perindopril-Based Antihypertensive Medications: An 11-Year Follow-Up, Real-World Evidence.
  • 7 Aug 2026
  • American journal of cardiovascular drugs : drugs, devices, and other interventions
When Methods Matter: An Umbrella Review of Lorundrostat and the Impact of Analytical Decisions on Reported Blood Pressure and Safety Outcomes.
  • 23 Jul 2026
  • American journal of cardiovascular drugs : drugs, devices, and other interventions
Aspirin Versus Clopidogrel as Single Antiplatelet Therapy After TAVI: A Propensity Score-Matched, Retrospective Analysis.
  • 21 Jul 2026
  • American journal of cardiovascular drugs : drugs, devices, and other interventions
Empagliflozin in STEMI Patients: A Randomized Controlled Trial on Left Ventricular Recovery and Cardiovascular Outcomes.
  • 17 Jul 2026
  • American journal of cardiovascular drugs : drugs, devices, and other interventions
Food Effects on the Pharmacokinetics of Single Dose and Steady-State Ralinepag, a Novel Oral Prostacyclin Agonist, in Healthy Volunteers.
  • 16 Jul 2026
  • American journal of cardiovascular drugs : drugs, devices, and other interventions

FAQs on American Journal of Cardiovascular Drugs